… design, synthesis, and serine protease inhibitory activity of a novel P 1-argininal derivative featuring a conformationally constrained P 2–P 3 bicyclic lactam moiety
SY Tamura, EA Goldman, TK Brunck, WC Ripka…
Index: Tamura, Susan Y.; Goldman, Erick A.; Brunck, Terence K.; Ripka, William C.; Semple, J. Edward Bioorganic and Medicinal Chemistry Letters, 1997 , vol. 7, # 3 p. 331 - 336
Full Text: HTML
Citation Number: 38
Abstract
Based on molecular modeling and judicious combination of the salient topographic features of the recently discovered P3-lactam derivative 1 with the P2-prolyl derivatives 2a, b, the novel thrombin inhibitor 3a was designed. Inhibitor 3a incorporates a fused bicyclic lactam as a novel type of P2–P3 dipeptide surrogate. The synthesis and biological activity of this potent serine protease inhibitor is presented.
Related Articles:
[Saladino, Raffaele; Mezzetti, Maurizio; Mincione, Enrico; Torrini, Ines; Paradisi, Mario Paglialunga; Mastropietro, Gaia Journal of Organic Chemistry, 1999 , vol. 64, # 23 p. 8468 - 8474]
[Saladino, Raffaele; Mezzetti, Maurizio; Mincione, Enrico; Torrini, Ines; Paradisi, Mario Paglialunga; Mastropietro, Gaia Journal of Organic Chemistry, 1999 , vol. 64, # 23 p. 8468 - 8474]
[Aggarwal, Varinder K.; Astle, Christopher J.; Iding, Hans; Wirz, Beat; Rogers-Evans, Mark Tetrahedron Letters, 2005 , vol. 46, # 6 p. 945 - 947]
[Aggarwal, Varinder K.; Astle, Christopher J.; Iding, Hans; Wirz, Beat; Rogers-Evans, Mark Tetrahedron Letters, 2005 , vol. 46, # 6 p. 945 - 947]